Laboratories Pharmaceutical in North Carolina

G1 Therapeutics, Inc, Durham

Durham / North Carolina / United States

0.0

Detail

Spyryx Bioscience, Durham

Durham / North Carolina / United States

0.0

Laboratories Pharmaceutical

Detail

Merck And Company Inc, Wilson

Wilson / North Carolina / United States

0.0

Laboratories Pharmaceutical

Detail

Quality Chemical Laboratories, Wilmington

Wilmington / North Carolina / United States

0.0

Detail

Alexion Pharmaceuticals, Inc, Raleigh

Raleigh / North Carolina / United States

0.0

Detail

A1 Labs Of Weston Salem, Winston Salem

Winston Salem / North Carolina / United States

0.0

Detail

Mayne Pharma US, Raleigh

Raleigh / North Carolina / United States

0.0

Laboratories Pharmaceutical

Detail

Glaxosmithkline, Zebulon

Zebulon / North Carolina / United States

0.0

GlaxoSmithKline is a pharmaceutical company that provides a range of research and development services for medicines and vaccines. It maintains a staff of more than 99,000 employees and has operations in over 100 countries. The company produces medicines for the treatment of HIV/AIDS, tuberculosis, malaria, asthma, diabetes and digestive diseases. GlaxoSmithKline offers medicines under the Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax brands. It also provides drugs for hepatitis A, diphtheria, cough, typhoid, influenza and mental health diseases. The company offers vitamins, allergy treatment medicines, and lip and ear care products. In addition, GlaxoSmithKline provides dermatological, gastrointestinal, respiratory and oral health care medicines.

Detail

Oriel Therapeutics Inc, Morrisville

Morrisville / North Carolina / United States

0.0

Detail

Midatech Pharma US Inc, Raleigh

Raleigh / North Carolina / United States

0.0

DARA BioSciences is a North Carolina-based development-stage pharmaceutical company that acquires promising therapeutic molecules and medical technologies directly or through investment in established companies. The company focuses its therapeutic development efforts on small molecules from late preclinical development through Phase 2 clinical trials. It has a portfolio of drug candidates for neuropathic pain, type 2 diabetes and psoriasis. DARA continues to build a diverse pipeline, including candidates for the treatment of metabolic diseases and pain. The company is currently conducting a Phase 2a trial for the treatment of neuropathic pain with KRN5500 and is in later stage preclinical development with a number of other programs. DARA BioSciences is headquartered in Raleigh, N.C.

Detail